5-question sleep apnoea screening — validated for Australian Medicare direct-referral criteria
The OSA50 is a validated screening tool for obstructive sleep apnoea (OSA). A score of 5 or more, combined with an Epworth Sleepiness Scale score of 8 or more, meets Medicare criteria for your GP to refer you directly for a sleep study — no specialist visit needed first.
The Medicare direct-referral criteria require both an OSA50 score ≥5 and an Epworth score ≥8. Complete both and share the results with your GP.
Go to Epworth Sleepiness Scale →Developed and validated by Chai-Coetzer et al. (2011) in an Australian primary care setting. Designed to identify moderate-to-severe OSA in adults, particularly in primary care. The tool gives extra weight to obesity (3 points) as the strongest single predictor of OSA severity.
Maximum score: 8 (3 + 1 + 2 + 1 + 1). A score of 5 or more has the best sensitivity/specificity balance for identifying moderate-to-severe OSA (AHI ≥15).
Limitation: Screening tools cannot diagnose sleep apnoea — only a sleep study can. A low score does not rule out OSA, particularly in women and younger adults who may present atypically.
| Question | Points (if Yes) |
|---|---|
| Obesity (BMI >35) | 3 |
| Snoring (loud) | 1 |
| Apnoeas (observed) | 2 |
| Age ≥50 | 1 |
| Blood pressure (high / treated) | 1 |
| Total | 8 |
A sleep study monitors your breathing, oxygen levels, heart rate, brain activity, and body movements while you sleep. A home study uses a portable device; an in-lab study is done at a sleep clinic overnight with a technician present. Your GP will recommend which type is appropriate. Learn more about sleep studies →
Neither is definitively better — both are validated and both meet Medicare referral criteria when combined with Epworth ≥8. OSA50 gives more weight to obesity; STOP-Bang includes neck circumference and sex. Your GP may use one or both.
Yes. Screening tools are designed to identify high-probability cases, but OSA can occur in people who score low — particularly women, younger adults, and those with mild disease. If you have significant symptoms, discuss them with your GP regardless of your score.